## Note
nid: 1475803122988
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::05_Cardio::06_Heart_Failure::05_Chronic_Heart_Failure, #AK_Step1_v11::#B&B::19_Renal::05_Other::03_Diuretics, #AK_Step1_v11::#FirstAid::14_Renal::05_Pharm::06_Potassium_Sparing_Diuretics, #AK_Step1_v11::#OME::14_Endocrine::02_Adrenal::03_Aldosterone, #AK_Step1_v11::#OME_banner::Clinical::01_Cardiology::02_Heart_Failure, #AK_Step1_v11::#Physeo::09_Pharm::06_Renal::05_Potassium-sparing_Diuretics, #AK_Step1_v11::#Pixorize::03_Pharm::17_Renal::Aldosterone_Receptor_Blockers_(Spironolactone,_Eplerenone), #AK_Step1_v11::#SketchyPharm::02_Cardio_&_Renal::02_Diuretics::04_K+_sparing_diuretics, #AK_Step1_v11::#UWorld::100-999::100-199::152, #AK_Step1_v11::#UWorld::100-999::600-699::686, #AK_Step1_v11::#UWorld::100-999::600-699::697, #AK_Step1_v11::^Other::^HighYield::1-HighYield, #AK_Step1_v11::^Systems::Renal::Pharmacology, #AK_Step2_v11::!Shelf::IM, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::#OME_banner::Basic_Science::12_Renal, #AK_Step2_v11::#Resources_by_rotation::IM::uw::renal::renal_dorian, #AK_Step2_v11::#Subjects::Endocrinology::03_Adrenal_Gland::Hyperaldosteronism_Conn_Syndrome::Treatment, #AK_Step2_v11::Original_decks::Dorian::im::uw::renal
markdown: false

### Text
<div>
  <b>{{c1::Eplerenone}}</b> and <b>{{c1::spironolactone}}</b> are
  {{c3::<b>K<sup>+</sup></b> <b>sparing</b>}} <b>diuretics</b> that
  act by <i>competitively</i> <u>antagonizing</u> the
  <b>{{c2::mineralocorticoid}} receptor</b>
</div>

### Extra
<img src="paste-355670536749546.jpg">
<div><img src="paste-355687716618732.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-210702505607171.jpg"><img src=
"paste-198809741164547.jpg">

### Sketchy
<div>
  <i>Sketchy Pharmacology: Renal (Diuretics)</i>
</div><img src=
"Screen%20Shot%202019-09-17%20at%209.37.04%20AM.png"> <img src=
"Screen%20Shot%202019-09-17%20at%209.37.11%20AM.png"> <img src=
"Screen%20Shot%202019-09-17%20at%209.37.18%20AM.png"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-cardiovascular-renal/videos/medical-pharmacology-cardiovascular-and-renal-diuretics-k-sparing-diuretics?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch K+ sparing diuretics</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/cardiology/heart-failure/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_5.png"></a>
</div>

### Additional Resources
<img src="big_5b6b0b591c50b.jpg" class="resizer"><img src=
"paste-c72f67936020eaae2aca90527c66a852f24a3266.jpg" class=
"resizer">
<div>
  <div>
    <div>
      Mechanism of action: potassium-sparing diuretics
    </div>
  </div>
  <div>
    <div>
      <div>
        Aldosterone and the cytosolic mineralocorticoid receptor
        form an intracellular complex, acting as a transcription
        factor for several transport proteins that move potassium,
        sodium, and water. Potassium-sparing diuretics (e.g.
        spironolactone, eplerenone) are aldosterone antagonists
        that inhibit the expression of these transport proteins, as
        well as basolateral Na+/K+-ATPases, through competitive
        binding of the aldosterone receptor. This leads to
        increased retention of potassium and increased excretion of
        sodium and water.
      </div>
    </div>
  </div>
</div>
<div>
  <i>can be used to treat primary hyperaldosteronism</i>
</div>
<div><img class="resizer" src="ph.png" style=""></div><img class=
"resizer" src="paste-2452336131702785.jpg" style="">

### One by one

